Cassava Sciences Management

Management criteria checks 3/4

Cassava Sciences' CEO is Rick Barry, appointed in Sep 2024, has a tenure of less than a year. directly owns 0.98% of the company’s shares, worth €1.37M. The average tenure of the management team and the board of directors is 2.2 years and 6.9 years respectively.

Key information

Rick Barry

Chief executive officer

US$546.2k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership1.0%
Management average tenure2.2yrs
Board average tenure6.9yrs

Recent management updates

Recent updates


CEO

Rick Barry (65 yo)

less than a year

Tenure

US$546,155

Compensation

Mr. Richard Jon Barry, also known as Rick, served as Independent Director at Cassava Sciences, Inc. since June 11, 2021, until July 17, 2024 and serves as its Executive Chairman of the Board since July 17,...


Leadership Team

NamePositionTenureCompensationOwnership
Richard Barry
CEO, President & Directorless than a yearUS$546.16k0.98%
€ 1.4m
Eric Schoen
Chief Financial Officer6.3yrsUS$2.99m0.024%
€ 33.7k
R. Cook
Senior VP2.3yrsUS$1.27m0%
€ 0
James Kupiec
Chief Medical Officer4yrsUS$2.97m0%
€ 0
George Thornton
Senior Vice President of Technologyno datano datano data
Michael Zamloot
Senior Vice President of Technical Operationsno datano datano data
Michael Marsman
Senior Vice President of Regulatory Affairs2.2yrsno datano data
Freda Nassif
Chief Commercial Officerless than a yearno datano data
Jaren Landen
Chief Clinical Development Officerless than a yearno datano data

2.2yrs

Average Tenure

62.5yo

Average Age

Experienced Management: PX91's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Richard Barry
CEO, President & Director3.6yrsUS$546.16k0.98%
€ 1.4m
Patrick Scannon
Independent Director17.1yrsUS$438.42k0.0025%
€ 3.5k
Michael O'Donnell
Independent Director26.6yrsUS$438.42k0.017%
€ 24.1k
Grant Schoenhard
Member of Scientific Advisory Board10.3yrsUS$558.31kno data
Robert Gussin
Independent Director21.8yrsUS$546.16k0.026%
€ 37.3k
Claude Nicaise
Independent Chairman1.1yrsUS$474.50k0%
€ 0
Robert Anderson
Independent Director1.1yrsUS$474.50k0%
€ 0
Pierre Gravier
Independent Director1.1yrsUS$474.50k0%
€ 0

6.9yrs

Average Tenure

68.5yo

Average Age

Experienced Board: PX91's board of directors are considered experienced (6.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 03:33
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cassava Sciences, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory FraserBofA Global Research
Mayank MamtaniB. Riley Securities, Inc.
Charles DuncanCantor Fitzgerald & Co.